Clinical Trial Update: UDCA for Symptomatic Gallstone Disease [Phase 4]

View source ↗

Summary

Phase 4 trial of ursodeoxycholic acid for symptomatic gallstone disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholelithiasis

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: UMC Utrecht | Conditions: Cholecystolithiasis | Phase 4 | Status: COMPLETED